Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PDD -9.3%, ATKR -8.2%, CAAP -7.2%, BEKE -6.8%, WMG -6.4%, CPA -6.1%, JACK -3.5%, MMS -3.4%, PANW -2.1%, BIDU -1.8%, NVDA -0.9%
Other news:
- PYXS -31% (preliminary PYX-201 clinical phase 1 data)
- KURA -20.5% (collaborating with Kyowa Kirin)
- BLZE -6.9% (prices follow-on offering of 6.25 mln shares of common stock at $5.60 per share)
- RNAC -5.5% (Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit)
- QSI -5% (analyst/investor event)
- ZLAB -2.7% (Zai Lab and Pfizer (PFE) form strategic collaboration on the novel antibacterial drug XACDURO)
- ESOA -1.6% (initiates quarterly dividend)
- SVM -1.4% (prices $130 mln of 4.75% convertible senior notes due 2029)
- RZLT -1.2% (receives FDA orphan designation for treatment of hypoglycemia due to tumor-associated hyperinsulinism)
- BLD -1% (to acquire Metro Supply Company)
- MYGN -1% (updates to its agreement with Illumina (ILMN))
- BWLP -1% (takes delivery of vessel BW Sirocco from Avance Gas; issues 1.35 mln new shares to Avance Gas)